Economic burden of treatment-resistant depression among veterans in the United States

References

• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington (VA): American Psychiatric Association; 2013.
   Google Scholar
• National Institute of Mental Health. Major depression [Internet]. Bethesda (MD): National Institute of Mental Health; 2019.
   Google Scholar
• National Institute of Mental Health. Major depression among adults [Internet]. Bethesda (MD): National Institute of Mental Health; 2017.
   Google Scholar
• Greenberg PE, Fournier AA, Sisitsky T, et al. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015;76(2):155–162.
   PubMed Web of Science ®Google Scholar
• Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64(12):1465–1475.
   PubMed Web of Science ®Google Scholar
• Gaynes BN, Asher G, Gartlehner G, et al. Definition of treatment-resistant depression in the Medicare population. Technology assessment program. Project ID: PSYT0816. (Prepared by RTI–UNC Evidence-Based Practice Center under Contract No. HSA290201500011I_HHSA29032006T). Rockville (MD): Agency for Healthcare Research and Quality; 2018 February 9.
   Google Scholar
• Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. AJP. 2006;163(11):1905–1917.
   Web of Science ®Google Scholar
• Kubitz N, Mehra M, Potluri RC, et al. Characterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims database. PLOS One. 2013;8(10):e76882.
   PubMed Web of Science ®Google Scholar
• Corey-Lisle PK, Birnbaum HG, Greenberg PE, et al. Identification of a claims data “signature” and economic consequences for treatment-resistant depression. J Clin. Psychiatry. 2002;63(8):717–726.
   PubMed Web of Science ®Google Scholar
• Ivanova JI, Birnbaum HG, Kidolezi Y, et al. Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder. Curr Med Res Opin. 2010;26(10):2475–2484.
   PubMed Web of Science ®Google Scholar
• Hoge CW, Castro CA, Messer SC, et al. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care.N Engl J Med. 2004;351(1):13–22.
   PubMed Web of Science ®Google Scholar
• Blore JD, Sim MR, Forbes AB, et al. Depression in Gulf War veterans: a systematic review and meta-analysis. Psychol Med. 2015;45(8):1565–1580.
   PubMed Web of Science ®Google Scholar
• Bonde JP, Utzon-Frank N, Bertelsen M, et al. Risk of depressive disorder following disasters and military deployment: systematic review with meta-analysis. Br J Psychiatry. 2016;208(4):330–336.
   PubMed Web of Science ®Google Scholar
• Seal KH, Metzler TJ, Gima KS, et al. Trends and risk factors for mental health diagnoses among Iraq and Afghanistan veterans using Department of Veterans Affairs health care, 2002–2008. Am J Public Health. 2009;99(9):1651–1658.
   PubMed Web of Science ®Google Scholar
• Spelman JF, Hunt SC, Seal KH, et al. Post deployment care for returning combat veterans. J Gen Intern Med. 2012;27(9):1200–1209.
   PubMed Web of Science ®Google Scholar
• Pietrzak RH, Goldstein MB, Malley JC, et al. Risk and protective factors associated with suicidal ideation in veterans of operations enduring freedom and Iraqi Freedom. J Affect Disord. 2010;123(1–3):102–107.
   PubMed Web of Science ®Google Scholar
• Li G, Fife D, Wang G, et al. All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population. Ann Gen Psychiatry. 2019;18(1):23.
   PubMed Web of Science ®Google Scholar
• Trivedi RB, Post EP, Sun H, et al. Prevalence, comorbidity, and prognosis of mental health among US veterans. Am J Public Health. 2015;105(12):2564–2569.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Heeringa SG, Stein MB, et al. Thirty-day prevalence of DSM-IV mental disorders among nondeployed soldiers in the US Army: results from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS). JAMA Psychiatry. 2014;71(5):504–513.
   PubMed Web of Science ®Google Scholar
• Zisook S, Tal I, Weingart K, et al. Characteristics of U.S. veteran patients with major depressive disorder who require “next-step” treatments: a VAST-D report. J Affect Disord. 2016;206:232–240.
   PubMed Web of Science ®Google Scholar
• Amos TB, Tandon N, Lefebvre P, et al. Direct and indirect cost burden and change of employment status in treatment-resistant depression: a matched-cohort study using a U.S. commercial claims database. J Clin Psychiatry. 2018;79(2):11725.
   Web of Science ®Google Scholar
• Benson C, Szukis H, Sheehan JJ, et al. An evaluation of the clinical and economic burden among older adult medicare-covered beneficiaries with treatment-resistant depression. Am J Geriatr Psychiatry. 2020;28(3):350–362.
   PubMed Web of Science ®Google Scholar
• Pilon D, Sheehan JJ, Szukis H, et al. Medicaid spending burden among beneficiaries with treatment-resistant depression. J Comp Eff Res. 2019;8(6):381–392.
   PubMed Web of Science ®Google Scholar
• Pilon D, Joshi K, Sheehan JJ, et al. Burden of treatment-resistant depression in Medicare: a retrospective claims database analysis. PLOS One. 2019;14(10):e0223255.
   PubMed Web of Science ®Google Scholar
• Pilon D, Szukis H, Joshi K, et al. US integrated delivery networks perspective on economic burden of patients with treatment-resistant depression: a retrospective matched-cohort study. Pharmacoecon Open. 2020;4(1):119–131.
   PubMed Web of Science ®Google Scholar
• Zhdanava M, Kuvadia H, Joshi K, et al. Economic burden of treatment-resistant depression in privately insured U.S. patients with physical conditions. J Manag Care Spec Pharm. 2020;26(8):996–1007.
   PubMed Web of Science ®Google Scholar
• Mercier A, Auger-Aubin I, Lebeau JP, et al. Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews. BMC Fam Pract. 2013;14:55.
   PubMed Web of Science ®Google Scholar
• Trivedi MH, Rush AJ, Wisniewski SR, et al., STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. AJP. 2006;163(1):28–40.
   Web of Science ®Google Scholar
• Rosenheck R. Mental health and substance abuse services for veterans: experience with mental health performance evaluation in the Department of Veterans Affairs. Improving the quality of health care for mental and substance-use conditions: quality chasm series. Washington (DC): Institute of Medicine Committee on Crossing the Quality Chasm: Adaptation to Mental Health and Addictive Disorders; 2004. p. 423–482.
   Google Scholar
• Hunt SC, Hoge CW. Health care for military veterans. In: Jameson JL, Fauci AS, Kasper DL, et al., editors. Harrison’s principles of internal medicine. 20th ed. New York (NY): McGraw-Hill Education; 2018.
   Google Scholar
• RAND Research. Improving the quality of mental health care for veterans: lessons from RAND Research (document number RB-10087); 2019.
   Google Scholar
• US Department of Veterans Affairs. Veterans community care program. 38 CFR part 17. RIN 2900-AQ46. Federal Register; 2019.
   Google Scholar
• US Department of Veterans Affairs. Veterans choice program (VCP) [Internet]. Washington (DC): US Department of Veterans Affairs; 2019 June 6.
   Google Scholar